Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 1, 2012, Pages 6-15

  Fazil, Mohammad ^a   Md, Shadab ^a   Haque, Shadabul ^a   Kumar, Manish ^b   Baboota, Sanjula ^a   Sahni, Jasjeet Kaur ^a   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Biodistribution; Brain targeting; Confocal microscopy; Intranasal route; Nanoparticles; Rivastigmine

Indexed keywords

CHITOSAN; RHODAMINE 123; RIVASTIGMINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN TARGETING; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; DRUG TARGETING; DRUG TRANSPORT; ENCAPSULATION; FEMALE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD-BRAIN BARRIER; BRAIN; CHITOSAN; DRUG CARRIERS; FEMALE; MALE; MICROSCOPY, CONFOCAL; NANOPARTICLES; NEUROPROTECTIVE AGENTS; PARTICLE SIZE; PERMEABILITY; PHENYLCARBAMATES; RATS; RATS, WISTAR;

EID: 84861115952     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.04.013     Document Type: Article

References (38)

1. Y. Aktas, K. Andrieux, M.J. Alonso, P. Calvo, R.N. Gürsoy, P. Couvreur, and Y. Capan Preparation and in vitro evaluation of chitosan NPs containing a caspase inhibitor Int. J. Pharm. 298 2005 378 383
2. H. Aminia, and A. Ahmadiani High-performance liquid chromatographic determination of rivastigmine in human plasma for application in pharmacokinetic studies Iranian. J. Pharm. Res. 9 2010 115 121
3. M.R. Avadi, A.M.M. Sadeghi, N. Mohammadpour, S. Abedin, F. Atyabi, R. Dinarvand, and M.M. Rafiee-Tehrani Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method Nanomed: Nanotech. Biol. Med. 6 2010 58 63
4. G. Borchard, H.L. Luessen, A.G. deBoer, J.C. Verhoef, C.M. Lehr, and H.E. Junginger The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III effects of chitosanglutamate and carbomer on epithelial tight junctions in vitro J. Control Release 39 1996 131 138
5. P. Calvo, C. Remunan-Lopez, J.L. Vila-Jata, and M.J. Alonso Chitosan and chitosan: ethylene oxide-propylene oxide block copolymer NPs as novel carriers for proteins and vaccines Pharm. Res. 14 1997 1431 1436
6. V. Dodane, M.A. Khan, and J.R. Merwin Effect of chitosan on epithelial permeability and structure Int. J. Pharm. 182 1999 21 32
7. A.R. Dudhani, and S.L. Kosaraju Bioadhesive chitosan NPs: Preparation and characterization Carbohyd. Polym. 81 2010 243 251
8. W. Fan, W. Yan, Z. Xu, and H. Ni Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique Colloids Surf., B 90 2012 21 27
9. H. Ge, Y. Hu, X. Jiang, D. Cheng, Y. Yuan, H. Bi, and C. Yang Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(e-caprolactone)-poly(ethylene oxide)-poly(e-caprolactone) amphiphilic triblock copolymer micelles J. Pharm. Sci. 91 2002 1463 1473
10. A.M. Ghananeem, H. Saeed, R. Florence, R.A. Yokel, and A.H. Malkawi Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses J. Drug. Target 18 2010 381 388
11. M.L. Hans, and A.M. Lowman Biodegradable NPs for drug delivery and targeting Curr. Opin. Solid State Mater. Sci. 6 4 2002 319 327
12. Y. Hu, X. Jiang, Y. Ding, H. Ge, Y. Yuan, and C. Yang Synthesis and characterization of chitosan-poly(acrylic acid) NPs Biomaterials 23 15 2002 3193 3201
13. S.A. Joshi, S.S. Chavhan, and K.K. Sawant Rivastigmine-loaded PLGA and PBCA NPs: Preparation, optimization, characterization, in vitro and pharmacodynamic studies Eur. J. Pharm. Biopharm. 76 2010 189 199
14. S. Khan, K. Patil, N. Bobade, P. Yeole, and R. Gaikwad Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats J. Drug. Target 18 2010 223 234
15. T. Kosasa, Y. Kuriya, K. Matsui, and Y. Yarnanishi Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats Eur. J. Pharmacol. 386 1999 7 13
16. M. Kumar, A. Misra, A.K. Babbar, A.K. Mishra, P. Mishra, and K. Pathak Intranasal nanoemulsion based brain targeting drug delivery system of risperidone Int. J. Pharm. 358 2008 285 291
17. LaPorte, K., Wu, Y., 2007. Dissolution Testing of an Extended Release Rivastigmine Tartrate Solid Oral Dosage by HPLC. SCOLR Pharma Inc, AAPS Annual Meeting & Exposition.
18. R. Lobenberg, L. Araujo, H. von Briesen, E. Rodgers, and J. Kreuter Body distribution of azidothymidine bound to hexylcyanoacrylate nanoparticles after i.v. injection to rats J. Control Release 50 1998 21 30
19. P.R. Lockman, R.J. Mumper, M.A. Khan, and D.D. Allen Nanoparticle technology for drug delivery across blood-brain barrier Drug Dev. Ind. Pharm. 28 2002 1 12
20. A. Misra, S. Ganesh, A. Shahiwala, and S.P. Shah Drug delivery to the central nervous system: a review J. Pharm. Pharmaceut. Sci. 6 2 2003 252 273
21. V.J. Mohanraj, and Y. Chen NPs - a review Trop. J. Pharm. Res. 5 2006 561 573
22. S.K. Motwani, S. Chopra, S. Talegaonkar, K. Kohli, F.Z. Ahmed, and R.K. Khar Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimization and in vitro characterization Eur. J. Pharm. Biopharm. 68 3 2008 513 525
23. R.H. Muller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19
24. S. Papadimitriou, D. Bikiaris, K. Avgoustakis, E. Karavas, and M. Georgarakis Chitosan NPs loaded with dorzolamide and pramipexole Carbohyd. Polym. 73 1 2008 44 54
25. C. Porporatto, I.D. Bianco, and S.G. Correa Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration J. Leukocyte Biol. 78 2005 62 69
26. Z. Qizhi, X. Jiang, W. Xiang, W. Lu, L. Su, and Z. Shi Preparation of nimodipine loaded microemulsion for intranasal delivery and evaluation of the targeting efficiency to brain Int. J. Pharm. 275 2004 85 96
27. B. Ray, and D.K. Lahiri Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin Curr. Opin. Pharmacol. 9 2009 434 444
28. T. Richter, and S. Keipert In vitro permeation studies comparing bovine nasal mucosa, porcine cornea and artificial membrane: androstenedione in microemulsions and their components Eur. J. Pharm. Biopharm. 58 2004 137 143
29. P.L. Ritger, and N.A. Peppas A simple equation for description of solute release II. Fickian and anomalous release from swellable devices J. Control Release 5 1987 37 42
30. A. Sadeghi, F.A. Dorkoosh, M.R. Avadi, P. Saadat, M. Rafiee-Tehrani, and H.E. Junginger Preparation, characterization and antibacterial activities of chitosan, TMC and DEMC nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods Int. J. Pharm. 355 2008 299 306
31. J.K. Sahni, S. Doggui, J. Ali, S. Baboota, L. Dao, and C. Ramassamy Neurotherapeutic applications of NPs in Alzheimer's disease J. Control Release 152 2011 208 231
32. G. Tosi, L. Costantino, F. Rivasi, B. Ruozi, E. Leo, A.V. Vergoni, R. Tacchi, A. Bertolini, M.A. Vandelli, and F. Forni Targeting the central nervous system: In vivo experiments with peptide-derivatized NPs loaded with Loperamide and Rhodamine-123 J. Control Release 122 2007 1 9
33. A.V. Vergoni, G. Tosi, R. Tacchi, M.A. Vandelli, A. Bertolini, and L. Costantino NPs as drug delivery agents specific for CNS: in vivo biodistribution Nanomed: Nanotech. Biol. Med. 5 2009 369 377
34. A. Vila, A. Sanchez, M. Tobío, P. Calvo, and M.J. Alonso Design of biodegradable particles for protein delivery J. Controll Release 78 2002 15 24
35. X. Wang, N. Chi, and X. Tang Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting Eur J. Pharm. Biopharm. 70 2008 735 740
36. B. Wilson, M.K. Samanta, K. Santhi, K. Sampath, M. Ramasamy, and B. Suresh Chitosan NPs as a new delivery system for the anti-Alzheimer drug tacrine Nanomed: Nanotech. Bio. Med. 6 1 2010 144 152
37. Y. Wu, W. Yang, C. Wang, J. Hu, and S. Fu Chitosan NPs as a novel delivery system for ammonium glycyrrhizinate Int. J. Pharm. 295 2005 235 245
38. S.B. Zhou, X.M. Deng, and X.H. Li Investigation on a novel core-coated microspheres protein delivery system J. Control Release 75 2001 27 36